Biomarkers of amyloid beta accumulation and tau‐mediated neuronal injury precede brain atrophy on structural magnetic resonance imaging (MRI) and the eventual clinical manifestation of AD (Sperling et al. 2011). Here, MAPT is linked to Alzheimer disease.